ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

St. Jude Begins $100 Million Expansion Program

December 4, 1987

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

Natcher Subcommittee Objects To Budget Reductions, Squeeze From DeVita Details On Programs Being Cut

March 15, 1985

In Brief: GM Awards Recognize Levine, Levy, Roeder, Tjian; U.S. Science, Tech Medals Awarded

May 14, 1999

It’s Official : PRI Wins Massive FCRF Contract ; DMS Keeps Library, Lands Computer Servicea

September 18, 1987

Nominations Open for Bristol-Myers $25,000

September 29, 1978